List of Tables
Table 1. Global Targeted Alpha-particle Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Actinium-225
Table 3. Key Players of Astatine-211
Table 4. Key Players of Lead-212
Table 5. Key Players of Bismuth-213
Table 6. Key Players of Others
Table 7. Global Targeted Alpha-particle Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Targeted Alpha-particle Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Targeted Alpha-particle Therapy Market Size by Region (US$ Million), 2021–2026
Table 10. Global Targeted Alpha-particle Therapy Market Share by Region (2021–2026)
Table 11. Global Targeted Alpha-particle Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Targeted Alpha-particle Therapy Market Share by Region (2027–2032)
Table 13. Targeted Alpha-particle Therapy Market Trends
Table 14. Targeted Alpha-particle Therapy Market Drivers
Table 15. Targeted Alpha-particle Therapy Market Challenges
Table 16. Targeted Alpha-particle Therapy Market Restraints
Table 17. Global Targeted Alpha-particle Therapy Revenue by Players (US$ Million), 2021–2026
Table 18. Global Targeted Alpha-particle Therapy Market Share by Players (2021–2026)
Table 19. Global Top Targeted Alpha-particle Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted Alpha-particle Therapy Revenue, 2025
Table 20. Ranking of Global Top Targeted Alpha-particle Therapy Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Targeted Alpha-particle Therapy Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Targeted Alpha-particle Therapy, Headquarters and Area Served
Table 23. Global Key Players of Targeted Alpha-particle Therapy, Products and Applications
Table 24. Global Key Players of Targeted Alpha-particle Therapy, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Targeted Alpha-particle Therapy Market Size by Type (US$ Million), 2021–2026
Table 27. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2021–2026)
Table 28. Global Targeted Alpha-particle Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2027–2032)
Table 30. Global Targeted Alpha-particle Therapy Market Size by Application (US$ Million), 2021–2026
Table 31. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2021–2026)
Table 32. Global Targeted Alpha-particle Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2027–2032)
Table 34. North America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. North America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Targeted Alpha-particle Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 49. Bayer Company Details
Table 50. Bayer Business Overview
Table 51. Bayer Targeted Alpha-particle Therapy Product
Table 52. Bayer Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 53. Bayer Recent Development
Table 54. Orano Med Company Details
Table 55. Orano Med Business Overview
Table 56. Orano Med Targeted Alpha-particle Therapy Product
Table 57. Orano Med Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 58. Orano Med Recent Development
Table 59. Oncoinvent AS Company Details
Table 60. Oncoinvent AS Business Overview
Table 61. Oncoinvent AS Targeted Alpha-particle Therapy Product
Table 62. Oncoinvent AS Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 63. Oncoinvent AS Recent Development
Table 64. Perspective Therapeutics Company Details
Table 65. Perspective Therapeutics Business Overview
Table 66. Perspective Therapeutics Targeted Alpha-particle Therapy Product
Table 67. Perspective Therapeutics Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 68. Perspective Therapeutics Recent Development
Table 69. Ablaze Pharma Company Details
Table 70. Ablaze Pharma Business Overview
Table 71. Ablaze Pharma Targeted Alpha-particle Therapy Product
Table 72. Ablaze Pharma Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 73. Ablaze Pharma Recent Development
Table 74. ARTBIO Company Details
Table 75. ARTBIO Business Overview
Table 76. ARTBIO Targeted Alpha-particle Therapy Product
Table 77. ARTBIO Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 78. ARTBIO Recent Development
Table 79. Fusion Pharmaceuticals(AstraZeneca) Company Details
Table 80. Fusion Pharmaceuticals(AstraZeneca) Business Overview
Table 81. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product
Table 82. Fusion Pharmaceuticals(AstraZeneca) Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 83. Fusion Pharmaceuticals(AstraZeneca) Recent Development
Table 84. AlphaGen Therapeutics Company Details
Table 85. AlphaGen Therapeutics Business Overview
Table 86. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product
Table 87. AlphaGen Therapeutics Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 88. AlphaGen Therapeutics Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Targeted Alpha-particle Therapy Picture
Figure 2. Global Targeted Alpha-particle Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Targeted Alpha-particle Therapy Market Share by Type: 2025 vs 2032
Figure 4. Actinium-225 Features
Figure 5. Astatine-211 Features
Figure 6. Lead-212 Features
Figure 7. Bismuth-213 Features
Figure 8. Others Features
Figure 9. Global Targeted Alpha-particle Therapy Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Targeted Alpha-particle Therapy Market Share by Application: 2025 vs 2032
Figure 11. Immunotherapy Case Studies
Figure 12. Peritoneal Carcinomas Case Studies
Figure 13. Bone Metastases Case Studies
Figure 14. Leukaemia Case Studies
Figure 15. Melanomas Case Studies
Figure 16. Solid Tumours Case Studies
Figure 17. Targeted Alpha-particle Therapy Report Years Considered
Figure 18. Global Targeted Alpha-particle Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 19. Global Targeted Alpha-particle Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Targeted Alpha-particle Therapy Market Share by Region: 2025 vs 2032
Figure 21. Global Targeted Alpha-particle Therapy Market Share by Players in 2025
Figure 22. Global Targeted Alpha-particle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Targeted Alpha-particle Therapy Revenue in 2025
Figure 24. North America Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. North America Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 26. United States Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Canada Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 30. Germany Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. France Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. U.K. Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Italy Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Russia Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Ireland Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Targeted Alpha-particle Therapy Market Share by Region (2021–2032)
Figure 38. China Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Japan Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. South Korea Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Southeast Asia Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. India Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Australia & New Zealand Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 46. Mexico Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Brazil Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 50. Israel Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Saudi Arabia Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. UAE Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Bayer Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 54. Orano Med Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 55. Oncoinvent AS Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 56. Perspective Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 57. Ablaze Pharma Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 58. ARTBIO Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 59. Fusion Pharmaceuticals(AstraZeneca) Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 60. AlphaGen Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
